Guideline and recommendations for transparency

Recommendations for transparency

Release of information concerning new applications for marketing authorisation for medicinal products before and after the decision is made MT | pdf
Requests for access to PSURs (Periodic Safety Update Reports) (November 2009) | pdf
Agenda for product related issues (November 2008) | pdf